Gemma Salvadó, PhD

Gemma Salvadó, PhD, is an associate researcher at Lund University in Sweden with a background in physics and biomedical engineering. She completed her PhD at the Barcelonaßeta Brain Research Center in Spain, where she studied the preclinical stages of Alzheimer's disease using neuroimaging and fluid biomarkers. Her current research focuses on plasma and cerebrospinal fluid biomarkers to understand disease progression. Dr. Salvadó has authored 44 peer-reviewed articles, including 14 as the first author, many published in high-impact journals. Her work has received significant recognition, with a notable increase in citations (945/771 citations, h-index=17/13 [Scopus/Google Scholar]). She was awarded the prestigious Marie Sklodowska-Curie post-doctoral fellowship, along with other significant fellowships such as the Alzheimer's Association Research Fellowship and the Alzheimerfonden Fellowship. She has presented her research at esteemed conferences, earning the Junior Faculty Award at the AD/PD conference. Dr. Salvadó has contributed to two large European-funded projects, EPAD and AMYPAD, focused on Alzheimer's disease research. She also serves as a reviewer for esteemed journals and participates in reviewing grants and awards. Additionally, Dr. Salvadó has been a member of the Executive Committee of the Neuroimaging Professional Interest Area of the Alzheimer's Association. Her extensive contributions highlight her dedication and impact on Alzheimer's disease research.